Recombinant Urate Oxidase for Prevention of Hyperuricemia and Tumor Lysis Syndrome in Lymphoid Malignancies
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma
- Vol. 3 (4), 225-232
- https://doi.org/10.3816/clm.2003.n.003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Advances in the management of patients with non-Hodgkin’s lymphomaExpert Review of Anticancer Therapy, 2001
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Non-Hodgkin's Lymphoma in ChildhoodNew England Journal of Medicine, 1996
- Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphateThe American Journal of Medicine, 1990
- acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposideCancer, 1990
- Acute Uric Acid NephropathyMedical Clinics of North America, 1990
- Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphomaThe American Journal of Medicine, 1980
- American Burkitt's lymphoma: A clinicopathologic study of 30 casesThe American Journal of Medicine, 1975
- Uric acid excretion and renal function in the acute hyperuricemia of leukemiaThe American Journal of Medicine, 1964
- The Renal Complications of LeukemiaNew England Journal of Medicine, 1943